GlassScriptPhysician profile
Jay B Patel
NPI 1710273677
$332.56
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $38.26 · 2023: $13.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $56.51 | 2019 | |
| Genentech USA, INC. | $42.92 | 2019-2020 | |
| Pfizer INC. | $33.44 | 2019 | |
| Lilly USA, LLC | $21.78 | 2019 | |
| Allergan, INC. | $20.00 | 2019 | |
| Amgen INC. | $18.30 | 2019 | |
| Merck Sharp & Dohme LLC | $15.14 | 2019 | |
| Vericel Corporation | $13.76 | 2023 | Maci |
| Boston Scientific Corporation | $13.11 | 2019 | |
| Circassia INC. | $12.38 | 2019 | |
| Astellas Pharma US INC | $12.26 | 2019 | |
| Sanofi Pasteur INC. | $12.03 | 2019 | |
| Antares Pharma, INC. | $11.94 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.57 | 2020 | |
| Cranial Technologies, INC | $11.44 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $10.98 | 2019 | |
| Medtronic Minimed, INC. | $10.97 | 2019 | |
| Fidia Pharma USA INC. | $4.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.